Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Aytu Biopharma Inc (AYTU)

Aytu Biopharma Inc (AYTU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Aytu Biopharma Inc 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237 USA

www.aytubio.com Employees: 83 P: 720-437-6580

Sector:

Medical

Description:

Aytu BioScience, Inc. is a healthcare company which focused on commercialization of novel products in the field of urology. The company's marketed products consists of ProstaScint(R), Primsol(R) and MiOXSYS(TM) which addresses prostate cancer, urinary tract infections, male infertility and male sexual dysfunction. Aytu BioScience, Inc. is based in Englewood, Colorado.

Key Statistics

Overview:

Market Capitalization, $K 25,776
Enterprise Value, $K 16,646
Shares Outstanding, K 10,188
Annual Sales, $ 66,380 K
Annual Net Income, $ -13,560 K
Last Quarter Sales, $ 13,890 K
Last Quarter Net Income, $ 1,970 K
EBIT, $ 3,070 K
EBITDA, $ 8,560 K
60-Month Beta 0.28
% of Insider Shareholders 4.90%
% of Institutional Shareholders 33.49%
Float, K 9,689
% Float 95.10%
Short Interest 457
Short Float 4.49%
Short Volume Ratio 0.31

Growth:

1-Year Return 68.67%
3-Year Return -33.07%
5-Year Return -97.88%
5-Year Revenue Growth 140.25%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.08 on 11/13/25
Next Earnings Date 02/11/26
Earnings Per Share ttm -0.42
EPS Growth vs. Prev Qtr 69.23%
EPS Growth vs. Prev Year 60.00%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 01/06/23

AYTU Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 17.86%
Return-on-Assets % 3.93%
Profit Margin % -20.43%
Debt/Equity 1.17
Price/Sales 0.39
Price/Cash Flow 6.77
Price/Book 1.12
Book Value/Share 2.27
Interest Coverage -2.72
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar